without high-quality vital
registration data, we estimated prevalence and incidence with data
from
Evdakov, V.A.,
Starodubov, V.I.,
Oleynik, B.A.,
Sharafutdinova, N.Kh.,
Borisova, M.V.,
Plechev, V.V. (2023) -up, and timeliness of follow-up medical care
registration were examined to identify the factors that cause mortality
ГЕНЕТИЧЕСКИЕ ОСОБЕННОСТИ ПОПУЛЯЦИИ, ПРОЖИВАЮЩЕЙ НА ТЕРРИТОРИИ РЕСПУБЛИКИ БАШКОРТОСТАНЛогинова, М.А.,
Парамонов, И.В.,
В.Н. Павлов,
Сафуанова, Г.Ш.,
Loginova, M.A.,
Paramonov, I.V.,
Pavlov, V.N.,
Safuanova, G.Sh. (Вестник трансплантологии и искусственных органов, 2016) , the other one was
submitted for
registration. In this population 17 HLA-A, 29 – HLA-B, 13 – HLA-C, 13 – HLA